31Indexed trials
Market Rank #49 · Evidence Tier A
Thailand
Neuroscience Intelligence
Thailand neuroscience intelligence: 31 indexed trials, 1 institutions, research score 20.43.
9Recruiting
1Research institutions
20.4Research score
Evidence profile
21Sponsors
8Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 20 · ML priority 20 · Confidence 85 · Evidence 20.4
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
parkinsons11trials
epilepsy6trials
stroke5trials
multiple_sclerosis2trials
pain_neuropathy2trials
anxiety1trials
depression1trials
Leading indexed sponsors
Merck Sharp & Dohme LLC7trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials
UCB Pharma2trials
CHIMES Society1trials
IRCCS San Raffaele Roma1trials
International Rescue Committee1trials
Department of Medical Services Ministry of Public Health of Thailand1trials
Mae Fah Luang University1trials
Mahidol University1trials
Khon Kaen University1trials